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Continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) are frequently used inhospital for
treating respiratory failure, especially in treatment of acute cardiogenic pulmonary edema and exacerbation of
chronic obstructive pulmonary disease. Early initiation of treatment is important for success and introduction
already in the prehospital setting may be beneficial. Our goal was to assess the evidence for an effect of
prehospital CPAP or NIV as a supplement to standard medical treatment alone on the following outcome measures;
mortality, hospital length of stay, intensive care unit length of stay, and intubation rate. We undertook a systematic
review based on a search in the three databases: PubMed, EMBASE, and Cochrane. We included 12 studies in our
review, but only four of these were of acceptable size and quality to conclude on our endpoints of interest. All four
studies examine prehospital CPAP. Of these, only one small, randomized controlled trial shows a reduced mortality
rate and a reduced intubation rate with supplemental CPAP. The other three studies have neutral findings, but in
two of these a trend toward lower intubation rate is found. The effect of supplemental NIV has only been evaluated
in smaller studies with insufficient power to conclude on our endpoints. None of these studies have shown an
effect on neither mortality nor intubation rate, but two small, randomized controlled trials show a reduction in
intensive care unit length of stay and a trend toward lower intubation rate. The risk of both type two errors and
publication bias is evident, and the findings are not consistent enough to make solid conclusion on supplemental
prehospital NIV. Large, randomized controlled trials regarding the effect of NIV and CPAP as supplement to
standard medical treatment alone, in the prehospital setting, are needed.
Keywords: Prehospital, Continuous positive airway pressure, Noninvasive ventilation, Respiratory failure, Acute
pulmonary edema, Chronic obstructive pulmonary disease, Mortality, Hospital length of stay, Intensive care unit
length of stay, Intubation rateIntroduction
Dyspnea is a frequent symptom among patients in the
prehospital setting [1]. Common causes of nontraumatic
dyspnea are congestive heart failure, pneumonia, chronic
obstructive pulmonary disease, and asthma [1]. The ap-
plication of advanced airway management and alterna-
tive devices in the prehospital setting has recently been* Correspondence: skulebakke@hotmail.com
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physician-provided prehospital critical care [2].
Continuous positive airway pressure (CPAP) and non-
invasive ventilation (NIV) are often used in intensive
care units for treating respiratory failure caused by acute
cardiogenic pulmonary edema (ACPE) and acute exacer-
bation of chronic obstructive pulmonary disease
(COPD). CPAP-systems apply positive airway pressure
with only minimal differences in the pressure applied
during inspiration and expiration [3]. The term NIV
covers different forms of noninvasive positive pressure
ventilation, which in contrast to CPAP can also ad extratd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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positive pressure ventilation [3,4]. Standard medical treat-
ment given for acute respiratory failure is diverse, depend-
ing on assumed cause and type of emergency medical
staffing. It ranges from simple supplemental oxygen ther-
apy to nitrates, diuretics, opioids, inhaled bronchodilators,
and inotropic infusions. The worst cases can result in
endotracheal intubation.
Recent Cochrane reviews show lower mortality and
reduced intubation rate with the use of inhospital supple-
mental CPAP and NIV, compared to standard medical
treatment alone, in patients with ACPE and exacerbations
of COPD [5,6]. Lower intubation rates decrease the risk of
complications related to endotracheal intubation and inva-
sive ventilation, especially pulmonary infections [7-9].
Prehospital intubation is associated with high success-
rates in physician-staffed services [10]. However, aspir-
ation of gastric contents during intubation is reported
more frequent in the prehospital setting than in the
emergency department [11]. One study reports compli-
cations in 14% of prehospital advanced airway manage-
ments [12]. Especially vomiting, hypotension, and
hypoxia do occur, but only a minor proportion of the pa-
tients in this study would have been suitable for CPAP/
NIV as only 21% were intubated because of hypoxia.
More than half of the patients had cardiac arrest. A pre-
requisite for successful noninvasive treatment is early initi-
ation of CPAP or NIV [13,14]. Thus it is reasonable to
believe that many patients would benefit from earlier initi-
ation of noninvasive treatment, in the prehospital setting,
to avoid intubation and improve patient outcome.
The objective of this systematic review of controlled
studies was to examine, whether CPAP or NIV initiated in
the prehospital setting reduce mortality, abbreviate hospital
length of stay (H-LOS), abbreviate intensive care unit
length of stay (ICU-LOS), or lower intubation rate when
used as a supplement to standard medical treatment alone.
Review
Methods
Published studies relevant for this review were identi-
fied by a search in the databases PubMed, EMBASE,
and Cochrane on April 4th 2013 and updated January
19th 2014. Our inclusion criteria were: Controlled stud-
ies examining the effect of supplemental prehospital
CPAP or NIV, compared to standard medical treatment
alone, in adult patients with acute respiratory failure of
any cause. In PubMed the following search string was
used: (“Continuous Positive Airway Pressure” [Mesh]
OR “Noninvasive Ventilation” [Mesh] OR non invasive
ventilation) AND (“Respiratory Insufficiency” [Mesh]
OR “Pulmonary disease, Chronic obstructive” [Mesh] OR
“Heart Failure”[Mesh] OR “Pulmonary Edema” [Mesh] OR
“Asthma” [Mesh]) AND (“Emergency medical services”[Mesh] OR prehospital OR pre-hospital OR out of
hospital).
We systematically excluded studies that did not meet
the inclusion criteria in a hierarchical manner according
to the following exclusion criteria:
1. Studies not regarding CPAP or NIV
2. Not prehospital setting
3. Not acute respiratory failure of any cause
4. Not a clinical trial
5. Not a controlled design comparing supplemental
CPAP or NIV to standard medical treatment alone
6. Not adult patients (≥18 years)
7. Abstract only
First the title of a study, as it appeared from the search
pages in the respective databases, was read and searched
for the exclusion criteria described above. If a study could
not be excluded based on its title, the abstract was read.
Based on the abstract, we excluded studies that did not
meet the inclusion criteria in the same hierarchical manner.
If exclusion could not be done based on the abstract, the
entire article was read. By this selection process, studies
with inhome use of noninvasive ventilation for chronic pul-
monary disorders, CPAP or NIV during intrahospital trans-
port, expert opinions, editorials, reports, and case series
were excluded. Duplications and conference abstracts were
removed. Two reviewers independently carried out the
searches, and discrepancies regarding exclusion were solved
by consensus. Subsequently, a hand-search through refer-
ences in the included studies, relevant reviews, and the
“related citations” feature on PubMed was performed. Two
reviewers independently extracted study details from the
included articles, searching for our endpoints of interest:
mortality, H-LOS, ICU-LOS, and intubation rate. Discrep-
ancies regarding data extraction were solved by consensus.
The included studies were independently evaluated by two
reviewers according to the Scottish Intercollegiate Guide-
lines Network 50 (SIGN 50) checklist for randomized and/
or controlled trials [15]. SIGN implements the Grading of
Recommendations Assessment, Development, and Evalu-
ation (GRADE) Working Groups approach within its meth-
odology. The SIGN 50 checklists section one shows quality
of evidence rated in one of four categories (ranging from
“well covered” to “not addressed”). Section two starts by
rating the methodological quality of the study, based on
answers in section one and using the following coding sys-
tem: High quality (++): The majority of criteria are met.
There is little risk of bias. Results are unlikely to be chan-
ged by further research. Acceptable quality (+): Most of
the criteria are met. There could be some flaws in the
study with an associated risk of bias. Conclusions may be
changed by further research. Low quality (−): Either most
criteria are not met, or there are significant flaws relating
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included studies would be heterogeneous, but used the
same checklist to assess all types of controlled studies
in order to improve the systematic approach and crit-
ical evaluation.
To minimize bias, two reviewers evaluated each
study independently. Differences in assessment were
discussed and discrepancies solved by consensus with
a third reviewer. We have presented the results from
all studies, but our conclusion is based only on studies
rated + or ++.
Results
We located 196 published studies searching PubMed,
290 studies searching EMBASE, and 228 studies search-
ing Cochrane, yielding a total of 714 studies. Of these,
700 studies were excluded based on titles or abstracts.
One study was found by hand-search [16] and, a total
of 15 full-text articles, were read (Figure 1). We subse-
quently excluded one study that examines CPAP alone
compared to CPAP and standard medical treatment
[17]. Another study examines CPAP and medical treat-
ment given at different time intervals, and not supple-
mental CPAP compared to standard medical treatment 
PubMed, Embase and Cochrane search
April 2013 and updated January 2014
228 titles reviewed in Cochrane
290 titles reviewed in Embase
196 titles reviewed in PubMed
126 abstracts reviewed 
14 (+ 1 article from 
hand-search) reviewed 
in full text 
12 articles met inclusion criteria
Figure 1 Search flow diagram.alone. It was therefore excluded [18]. Finally, one study
was excluded because it is a cost-benefit analysis and
not a clinical trial [19]. One study does not report if
standard medical treatment was used in the interven-
tion group and an email was sent to the corresponding
author for clarification, but there was no reply. Based
on our evaluation of the methods section, both inter-
vention and control groups received medical treatment
and the study was thus included for analysis [20]. Another
study does not state a primary endpoint, but reports on
endpoints of interest for our review and was therefore in-
cluded [21]. Thus we included 12 studies for final analysis
[16,20-30]. Of the included studies, eight studies examine
CPAP as intervention [16,22-25,27,28,30] and four studies
examine NIV as intervention [20,21,26,29].
Overview of study design and main findings of the
studies can be found in Table 1. According to our evalu-
ation of clarity and quality of the included studies, by
use of the SIGN 50 checklist, eight studies either lack
power to conclude on our outcomes of interest or entails
high risk of bias [20-22,24-27,29]. Four studies have ac-
ceptable power and risk of bias [16,23,28,30]. The clarity
and quality of the studies, according to the SIGN 50
checklist, is shown in Table 2.112 abstracts excluded
4    - Not regarding NIV or CPAP
33  - Not prehospital setting
6    - Not acute respiratory failure of any cause
39  - Not a clinical trial
12  - Not a controlled design
0    - Not adult patient
7    - Abstract
11  - Duplications
3 articles excluded 
588 titles excluded
354 - Not regarding NIV or CPAP
86   - Not prehospital setting
54   - Not acute respiratory failure of any cause
45   - Not a clinical trial
34   - Not a controlled design
7     - Not adult patient
8     - Abstract
Table 1 Characteristics of included studies comparing standard medical treatment with supplementary CPAP or NIV
Study Study
Country















Cheskes et al. [16] Canada CPAP Observational,
before-and-after




































Ducros et al. [30] France CPAP Randomized,
controlled
multicentre
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(p=0.67)
Frontin et al. [28] France CPAP Randomized,
controlled
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Table 1 Characteristics of included studies comparing standard medical treatment with supplementary CPAP or NIV (Continued)
Gardtman et al. [22] Sweden CPAP Observational,
before-and-after


















35 Interventions 1/35 ARF of any
cause
Mortality, adjusted Odds ratio 0.06
(0.01-0.53)
Mortality: ↓
















Intubation rate Odds ratio
4.04 (1.64-9.95)
Mortality: ↓










Thompson et al. [23] Canada CPAP Randomized, controlled 35 Interventions 5/35 ARF of any
cause
Intubation rate Odds ratio
0.16 (0.04-0.7)
Mortality: ↓





6.5 vs. 3 days




Craven et al. [29] USA NIV Prospective, demographically
controlled
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(p=0,5)





























Table 1 Characteristics of included studies comparing standard medical treatment with supplementary CPAP or NIV (Continued)
Schmidbauer et al.
[21]
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All comparisons are intervention vs. control. Arrows showing; no difference →, improvement/reduction ↓.
(Continuous positive airway pressure, CPAP; Positive pressure ventilation, PPV; Acute respiratory failure, ARF; Acute cardiogenic pulmonary edema, ACPE; Chronic obstructive pulmonary disease, COPD; Intubation rate,

























































and clearly focused question
•••• •• •••• •••• ••• •••• •••• •••• •••• •••• •• •••
1.2 The assignment of subjects
to treatment groups randomised




NA NA • •••• NA NA NA •••• NA •••• •••• •
1.4 Subjects and investigators
are kept ‘blind’ to treatment
allocation
NA NA •• ••• NA NA NA ••• NA • • •
1.5 The treatment and control
groups were similar at the
start of the trial
••• •• •••• •••• ••• •• •• ••• •• •••• ••• ••
1.6 The only difference between
the groups is the treatment
under investigation
••• •• •••• •••• •• •• •• ••• ••• •• •••• ••
1.7 All relevant outcomes
measured in a standard,
valid and reliable way
•••• ••• ••• ••• •• ••• ••• •••• •••• ••• ••• •••
1.8 What percentage of the
individuals or clusters recruited
into each treatment arm of the

















1.9 All the subjects are
analysed in the groups
to which they
were (randomly) allocated
••• NA •••• •••• •••• NA •••• •••• •• ••• • •••
1.10 Where the study
is carried out at more























Table 2 Clarity and quality of the included studies (Continued)
than one site, results
are comparable for all sites
2.1 How well was the
study done to minimise bias?
+ - ++ ++ - - - + - + + -
2.2 Taking into account
clinical considerations,
your evaluation of the
methodolgy used, and
the statistical power of
the study, are you certain
that the overall effect i
s due to the study intervention?
+ - + + - - - + - - - -
2.3 Are the results of this study directly applicable to
the patient group targeted by this review?
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Some criteria fulfilled +
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In the eight studies comparing supplemental CPAP to
standard medical treatment alone, the number of pa-
tients in the intervention groups ranges between 35 and
214 [16,22-25,27,28,30]. Three studies are randomized
controlled trials [23,28,30]. One study is prospective but
not randomized [24]. Three studies are before and after
studies [16,22,25]. One study is a cross-sectional study,
where outcomes of patients receiving CPAP are com-
pared to outcomes from those not receiving this inter-
vention [27]. In three studies comparing supplemental
CPAP to standard medical treatment alone, a reduction
in mortality is found [23-25]. No studies show a signifi-
cant increase in mortality with administration of CPAP.
One study shows a lower H-LOS [25] and another study
reports no difference in H-LOS [22]. Three studies re-
port no difference in ICU-LOS [23,28,30]. Intubation
rate is reduced with supplemental CPAP treatment in
three studies [23,24,27]. According to our evaluation of
clarity and quality of the studies, four studies either lack
power to conclude on our outcomes of interest [25] or
entail high risk of bias [22,24,25,27] and were excluded
from contribution to our conclusion. Four studies have
acceptable power and risk of bias [16,23,28,30]. Of these,
one smaller randomized controlled trial shows a reduction
in both mortality and intubation rate [23]. The remaining
three – one large descriptive study and two randomized
and controlled studies show no effect on any of our out-
comes of interest [16,28,30], but there is a trend toward
lower intubation rate with supplementary CPAP in two of
these studies [28,30]. The prehospital, inhospital, and
overall intubation rates are shown in Table 3.
NIV
In the four studies comparing supplemental prehospital
NIV to standard medical treatment alone, the number of
patients in the intervention groups ranges between 10
and 37 [20,21,26,29]. Three of the studies have a ran-
domized and controlled design [20,21,26]. The fourth
study is a prospective controlled study with five rescue
units administering bi-level positive airway pressure as
intervention group and five units administering standard
medical treatment alone as control group [29]. There
was no difference in mortality with supplemental NIV
compared to standard medical treatment alone. In two
studies, a reduction in ICU-LOS is found [20,21]. One
study reports no difference in ICU-LOS [26]. No differ-
ence in total H-LOS is found in any of the studies. No
difference in intubation rate is shown in any of the stud-
ies. According to our evaluation of clarity and quality of
evidence, all four studies lack power to make conclu-
sions on our outcomes of interest [20,21,26,29] and two
studies entail high risk of bias [26,29]. In two small stud-
ies with low risk of bias, a reduction in ICU-LOS and atrend toward decreased intubation rate with supplemen-
tal prehospital NIV is seen [20,21], see Table 3.
Discussion
Our principal findings are: 1) One of four studies of accept-
able quality shows a lower mortality and intubation rate
with supplemental prehospital CPAP compared to stand-
ard medical treatment alone, and the remaining three are
neutral. A trend toward lower intubation rate with supple-
mental prehospital CPAP is seen in two studies. 2) There is
insufficient evidence to conclude on the use of supplemen-
tal prehospital NIV.
CPAP
All the included studies are relatively small, and many
lack the power to investigate hard endpoints like mortal-
ity. Three studies did indeed find a reduced mortality
[23-25], but two studies had problems with the study
design [24,25]. The risk of type two statistical errors in
the included studies is high.
In the study by Cheskes et al. a trend towards in-
creased mortality in the subgroups chronic heart failure,
COPD and pulmonary edema was seen, but this was not
found in the other studies and their result was not statis-
tically significant [16].
Prehospital CPAP given as a supplement to standard
medical treatment improves clinical endpoints like re-
spiratory rate and arterial saturation [24,25,27], when
compared to standard medical treatment alone. In studies
where arterial gases were taken, an improvement was seen
[25,30]. PaO2 improved and pH was higher in the inter-
vention group in one study [25]. The other study showed
lower PCO2 and normalization of pH, but did not report
on PaO2 as an endpoint [30]. These findings, combined
with the lower intubation rate [23] and trend toward lower
intubation rates [28,30], indicate that CPAP may reduce
prehospital intubation rates, but this needs to be verified.
Whether or not this is beneficial, cannot be answered
based on the current evidence.
Of the four studies with acceptable quality, two included
patients with acute respiratory failure of any cause [16,23]
and two included patients with ACPE [28,30]. The low
number of studies does not allow us to conclude on differ-
ences between the conditions being treated for.
NIV
There is insufficient evidence to conclude on the effect of
supplemental prehospital NIV compared to standard med-
ical treatment alone. The failure to demonstrate differ-
ences in mortality, intubation rate, and H-LOS could be
caused by type two errors in these small studies. Thus this
does not mean that the strategy should be abandoned in
future research. Studies in patients with COPD indicate
that CPAP decreases inspiratory work of breathing [31].
Table 3 Intubation rates with supplemental prehospital CPAP/NIV compared to standard medical treatment alone
Study Supplemental prehospital CPAP/NIV Standard medical treatment alone
CPAP
Cheskes et al. 2013 31/214 30/228
Prehospital 0/124 1/228
Inhospital 31/214 29/228
Ducros et al. 2011 3/107 6/100
Prehospital NA NA
Inhospital NA NA
Frontin et al. 2011 2/60 3/62
Prehospital 0/60 1/62
Inhospital 2/60 2/62
Thompson et al. 2008 7/35 17/34*
Prehospital 0/35 9/34
Inhospital 7/35 8/34
Dib et al. 2012 NA NA
Prehospital 4/149 11/238*
Inhospital NA NA
Gardtman et al. 2000 NA NA
Prehospital NA NA
Inhospital NA NA
Garuti et al. 2010 0/35 14/125
Prehospital 0/35 14/125
Inhospital 0/35 0/125




Craven et al 2000 4/37 7/25
Prehospital 0/37 6/25
Inhospital 4/37 1/25
Roessler et al 2011 1/24 6/25
Prehospital 0/24 1/25
Inhospital 1/14 5/25
Schmidbauer et al 2011 3/18 7/18
Prehospital 1/18 0/18
Inhospital 2/18 0/18
Weitz et al 2007 NA NA
Prehospital NA NA
Inhospital NA NA
*=statistical significant difference. Studies rated as having acceptable size and quality are bold.
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end expiratory pressure, increases tidal volume in propor-
tion to the amount of pressure applied and theoretically
relives inspiratory muscles [32]. Thus theoretically, NIV
should be advantageous and in all of the included studies
measuring these, vital signs like respiratory rate improvewhen NIV is used. Arterial saturation significantly im-
proves with supplemental NIV compared to standard med-
ical treatment alone, including high fractions of inspired
oxygen, in three of the studies included in this review
[20,26,29]. In the fourth study, improvement in arterial sat-
uration was more pronounced in the intervention group,
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that these improvements in vital signs may lead to a better
patient outcome, but this was not demonstrated in the
included studies – most likely because of low sample sizes.
In both studies with acceptable risk of bias but low sample
size, a trend toward lower intubation rate with supplemen-
tary NIV, compared to standard medical treatment alone,
is found [20,21]. However, the small sample sizes in these
studies prohibit us from making solid conclusions on the
use of prehospital supplemental NIV.
General considerations
The equipment used to administer CPAP or NIV includes
an external pressure regulator (WhisperFlow [23,24,27,30]),
a turbulent flow valve (Boussignac [28]), helmet CPAP
(Castar-Starmed, Flow-meter [25]), a ventilatory system
(Respironics 330000 [29]) and a portable ventilator (Oxylog
3000 [20,21,26]). The last two devices are used to adminis-
ter NIV, and this equipment is technically more sophisti-
cated than the equipment used to deliver CPAP. The
medical staffing of the dispatched rescue teams in the in-
cluded studies was heterogeneous. Physicians administered
CPAP/NIV in five studies [20,21,26,28,30] and paramedics
or emergency medical technicians administered CPAP/NIV
in another five studies [16,23,24,27,29]. Nurses adminis-
tered CPAP in one study [25] and in one study both para-
medics and, for 25% of the time, nurses provided treatment
with CPAP [22]. Further comparison and analysis of the
equipment used, is beyond the scope of this review.
None of the studies included in this review report
problems with safety, or with easy of use, when adminis-
trating CPAP or NIV, regardless of the treating clini-
cians’ qualifications. Only physicians provided NIV with
the Oxylog 3000. The low number of included studies,
and their varying study design, does not allow us to
distinguish between conditions being treated for or to
compare those who administered CPAP.
A recent systematic review and meta-analysis of ran-
domized controlled trials on prehospital CPAP/NIV by
Mal et al. finds a reduction in the need for inhospital inva-
sive ventilation and mortality, with the use of prehospital
noninvasive positive pressure ventilation [33]. The review
by Mal et al. includes only randomized and controlled
studies. In their review, seven heterogeneous studies on
both CPAP and NIV, with a total of 632 patients, are
combined in a meta-analysis. They also included one study
that was excluded from our review [18]. This study by
Plaisance et al. compares different treatment algorithms,
both involving CPAP and medical treatment, at different
time intervals. A large proportion of the studies included
in the meta-analysis by Mal et al. were relatively small.
This can increase the risk of overestimating the effect of
the intervention due to publication bias, as small studies
with negative findings are less likely to be accepted forpublication. A recent review by Simpson et al. finds that
prehospital CPAP/NIV appears to be safe and feasible ther-
apy that results in faster improvement in physiological sta-
tus, and that it may decrease the need for intubation, when
compared to delayed administration in the emergency
department [34]. They state there is weak evidence that
NIV may decrease mortality, which is not in agreement
with our findings. In their review, the majority of articles
included are noncomparative descriptive studies only on
ACPE, and they included three studies that were excluded
from our review [17-19]. Simpson et al. recognized, but did
not discriminate between different forms of NIV.
Limitations
The risk of publication bias is, as for all reviews, a weak-
ness of this study. No studies in non-English languages
met our inclusion criteria, but among our excluded stud-
ies were studies published in German, Spanish, Japanese,
French, and Russian. However, there is a risk that studies
published in other languages than English to a lesser
extend are indexed in the searched databases. This can
theoretically produce an overestimation of the positive
effects of CPAP or NIV [35].
We used the SIGN 50 checklist designed for random-
ized controlled trials, because this checklist is relevant
when considering nonrandomized studies as well. These
study evaluations inevitably involve a degree of subjective
judgment.
The external validity of our review is difficult to
outline as the included studies are from different parts
of the world, with different geographic characteristics,
different medical staffing, and with different structure of
the emergency medical services. Standard medical treat-
ment used in the included studies cannot be regarded as
uniform, although medical treatment of acute exacerba-
tions of COPD and ACPE is well established. This could
make the results less comparable.
When considering all patients attended, few are intu-
bated in the prehospital setting [12,36,37]. In the Scandi-
navian countries, as in the majority in Europe, physicians
provide prehospital advanced airway management and
have the ability to intubate the trachea on scene. The treat-
ing clinicians in the included studies are often paramedics
and not experienced physicians – this may have influenced
intubation rates [38].
The pressures applied when administrating CPAP or
NIV varied among the included studies. Reported pres-
sure settings when administrating CPAP in the included
trials, ranged from 5 to 10 cm H2O. One study examin-
ing NIV adjusted pressures according to a predefined
protocol, and up to 20 cm H2O support pressure was
given [20]. Four studies did not report on pressure
settings [16,21,22,29]. Different pressure levels could be
clinically relevant when comparing interventions.
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Supplemental prehospital CPAP seems to improve vital
signs, compared to standard medical treatment alone,
and there is a trend toward lower intubation rate. This
needs to be confirmed in larger, randomized controlled
trials, and whether it is beneficial in terms of lower
mortality or morbidity also needs clarification.
Supplemental prehospital NIV, compared to standard
medical treatment alone, also seems to improve vital signs,
but it is unknown whether this affects patient outcome.
With regards to what we know from the inhospital setting,
it seems reasonable to include patients with acute exacer-
bations of COPD in future studies [6]. The application of
NIV in the prehospital setting, and thereby early initiation,
may be more advantageous in case of long distances to the
receiving hospitals; this could also be a focus for future
research. Interestingly, there were only few reported
problems with mask-tolerance in studies included in this
review – this is a well-described problem inhospital, and it
is unlikely that these issues are smaller in the prehospital
setting even if the treatment time is short. This subject –
and the patients’ perception of mask treatment, in the
prehospital setting, could also be a focus for future
research [39,40].
Conclusion
The current evidence shows no difference in mortality or
hospital length of stay, but a trend toward reduced intub-
ation rate with prehospital supplemental CPAP compared
to standard medical treatment alone. This needs to be veri-
fied in larger, randomized controlled trials. The current
evidence regarding prehospital supplemental NIV is scarce,
and the conducted studies are too small to make reason-
able conclusions, but justify further research.
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